Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial F Palhano-Fontes, D Barreto, H Onias, KC Andrade, MM Novaes, ... Psychological medicine 49 (4), 655-663, 2019 | 789 | 2019 |
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ... Revista brasileira de psiquiatria 37 (1), 13-20, 2015 | 585 | 2015 |
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study RF Sanches, F de Lima Osório, RG Dos Santos, LRH Macedo, ... Journal of clinical psychopharmacology 36 (1), 77-81, 2016 | 533 | 2016 |
Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics J Riba, M Valle, G Urbano, M Yritia, A Morte, MJ Barbanoj Journal of Pharmacology and Experimental Therapeutics 306 (1), 73-83, 2003 | 508 | 2003 |
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers J Riba, A Rodríguez-Fornells, G Urbano, A Morte, R Antonijoan, ... Psychopharmacology 154 (1), 85-95, 2001 | 405 | 2001 |
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study JC Bouso, D González, S Fondevila, M Cutchet, X Fernández, ... Public Library of Science 7 (8), e42421, 2012 | 391 | 2012 |
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the … RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak Therapeutic advances in psychopharmacology 6 (3), 193-213, 2016 | 345 | 2016 |
Dopamine modulates the reward experiences elicited by music L Ferreri, E Mas-Herrero, RJ Zatorre, P Ripollés, A Gomez-Andres, ... Proceedings of the National Academy of Sciences 116 (9), 3793-3798, 2019 | 337 | 2019 |
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant J Riba, S Romero, E Grasa, E Mena, I Carrió, MJ Barbanoj Psychopharmacology 186, 93-98, 2006 | 326 | 2006 |
Assessment of addiction severity among ritual users of ayahuasca JM Fábregas, D González, S Fondevila, M Cutchet, X Fernández, ... Drug and alcohol dependence 111 (3), 257-261, 2010 | 303 | 2010 |
Ayahuasca: Pharmacology, neuroscience and therapeutic potential E Domínguez-Clavé, J Soler, M Elices, JC Pascual, E Álvarez, ... Brain research bulletin 126, 89-101, 2016 | 269 | 2016 |
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans JC Bouso, F Palhano-Fontes, A Rodríguez-Fornells, S Ribeiro, ... European Neuropsychopharmacology 25 (4), 483-492, 2015 | 258 | 2015 |
The internationalization of ayahuasca BC Labate, H Jungaberle LIT Verlag Münster, 2011 | 256 | 2011 |
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities J Soler, M Elices, A Franquesa, S Barker, P Friedlander, A Feilding, ... Psychopharmacology 233, 823-829, 2016 | 238 | 2016 |
Pattern of use and subjective effects of Salvia divinorum among recreational users D González, J Riba, JC Bouso, G Gómez-Jarabo, MJ Barbanoj Drug and alcohol dependence 85 (2), 157-162, 2006 | 215 | 2006 |
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution MV Uthaug, K van Oorsouw, KPC Kuypers, M Van Boxtel, NJ Broers, ... Psychopharmacology 235, 2979-2989, 2018 | 201 | 2018 |
Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers J Riba, P Anderer, A Morte, G Urbano, F Jané, B Saletu, MJ Barbanoj British journal of clinical pharmacology 53 (6), 613-628, 2002 | 189 | 2002 |
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking KPC Kuypers, J Riba, M de la Fuente Revenga, S Barker, EL Theunissen, ... Psychopharmacology 233, 3395-3403, 2016 | 185 | 2016 |
Dopamine agonist increases risk taking but blunts reward-related brain activity J Riba, UM Krämer, M Heldmann, S Richter, TF Münte PloS one 3 (6), e2479, 2008 | 183 | 2008 |
Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low … J Riba, P Anderer, F Jané, B Saletu, MJ Barbanoj Neuropsychobiology 50 (1), 89-101, 2004 | 179 | 2004 |